Vanholder et al., 2008 - Google Patents

Uremic toxins: do we know enough to explain uremia?

Vanholder et al., 2008

Document ID
5189551365970906079
Author
Vanholder R
Meert N
Schepers E
Glorieux G
Publication year
Publication venue
Blood purification

External Links

Snippet

Background: The uremic syndrome is characterized by a complex clinical picture, whereby the function of multiple organ systems is affected by the retention of a host of solutes. Recent research of the last decade has helped to unravel multiple pathophysiologic mechanisms …
Continue reading at karger.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography

Similar Documents

Publication Publication Date Title
Vanholder et al. Uremic toxins: do we know enough to explain uremia?
Vanholder et al. What is new in uremic toxicity?
Fagugli et al. Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis
Lesaffer et al. Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane
US20210069400A1 (en) Methods and apparatus for kidney dialysis and extracorporeal detoxification
Böhringer et al. Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration
Fabresse et al. Quantification of free and protein bound uremic toxins in human serum by LC-MS/MS: comparison of rapid equilibrium dialysis and ultrafiltration
EP1852136A1 (en) Use of a dialysis membrane for preparing a haemodialysis unit for reducing blood free light chain concentration
Mares et al. Proteomic profiling of blood‐dialyzer interactome reveals involvement of lectin complement pathway in hemodialysis‐induced inflammatory response
Vanholder et al. New methods and technologies for measuring uremic toxins and quantifying dialysis adequacy
CN106039320A (en) Anti-nonspecific capture magnetic bead, and preparation method and application thereof
Hyšpler et al. Indoxyl sulfate elimination in renal replacement therapy: influence of citrate‐versus acetate‐buffering component during bicarbonate dialysis
Molina et al. Combining diffusion, convection and absorption: a pilot study of polymethylmethacrylate versus polysulfone membranes in the removal of P-cresyl sulfate by postdilution on-line hemodiafiltration
Vanholder et al. From uremic toxin retention to removal by convection: do we know enough?
Petucci et al. Capillary electrophoresis as a clinical tool determination of organic anions in normal and uremic serum using photodiode-array detection
Shetty et al. Investigation of plasma biomarkers in HIV-1/HCV mono-and coinfected individuals by multiplex iTRAQ quantitative proteomics
Bowry et al. The membrane perspective of uraemic toxins: which ones should, or can, be removed?
Wirkus et al. Development and application of novelty pretreatment method for the concurrent quantitation of eleven water-soluble B vitamins in ultrafiltrates after renal replacement therapy
Huang et al. The effect of increased frequency of hemodialysis on serum cystatin C and β2‐microglobulin concentrations: a secondary analysis of the frequent hemodialysis network (FHN) trial
Depner et al. Impaired plasma phenytoin binding in uremia: Effect of in vitro acidification and anion-exchange resin
Contreras et al. Molecules in the middle molecular weight range
Gay et al. Proteomic analysis of polypeptides captured from blood during extracorporeal albumin dialysis in patients with cholestasis and resistant pruritus
WO2007125338A1 (en) Immunoglobulin free light chain assay
Jiang et al. Demonstrating β‐glucan and yeast peptide clearance in biopharmaceutical downstream processes
US9448243B2 (en) Weak affinity chromatography